SCHEMBL14224537

SCHEMBL14224537

Cn1cc(NC(=O)c2cc3ccccc3cn2)cc1C(=O)Nc1cc(-c2nc3cc(N)ccc3[nH]2)n(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
MAPK1 P28482 2/20 0.39
CBLB Q13191 8/20 0.38
ADORA2A P29274 1/20 0.38
ABCB1 P08183 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36
PDGFRA P16234 1/20 0.36
FLT3 P36888 1/20 0.36
EGFR P00533 2/20 0.35
RAB9A P51151 2/20 0.35
USP2 O75604 1/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14426980 0.91 MAPT (0.39) MAPTMAPK1CBLBABCB1ABCG2
SCHEMBL14427363 0.91 MAPT (0.39) MAPTMAPK1CBLBABCB1ABCG2
SCHEMBL14224534 0.87 MAPT (0.40) MAPTMAPK1CBLBABCB1ABCG2
SCHEMBL14426984 0.85 MAPT (0.41) MAPTMAPK1CBLBABCB1ABCG2
SCHEMBL14224673 0.81 PDGFRB (0.45) ABCB1ABCG2PDGFRBPDGFRAEGFR
SCHEMBL14224528 0.81 KDM4E (0.43) ABCB1ABCG2EGFRRAB9APOLB
SCHEMBL14224524 0.79 MAPT (0.37) MAPTMAPK1CBLBEGFRRAB9A
SCHEMBL1201768 0.75 RAB9A (0.46) MAPTADORA2ARAB9AMEN1KMT2A
SCHEMBL14224525 0.75 MAPT (0.35) MAPTMAPK1CBLBCSF1RRET
SCHEMBL14224554 0.74 EGFR (0.52) CBLBABCB1ABCG2CSF1RRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS GENESOFT PHARMACEUTICALS, INC. (US) 2008-04-17 US disclosed
US-7265129-B2 Anti-infective biaryl compounds GENESOFT PHARMACEUTICALS, INC. (US) 2007-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090816-A1 ANTI-INFECTIVE BIARYL COMPOUNDS QTRT1, Q6ZSR9, QTRT2 MAPT 4305/4885MAPK1 4075/4885CBLB 4459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.